Most bought healthcare stocks in Q1 2024
Discover which Healthcare stocks institutional investors added to most aggressively over Q1 2024 versus the prior calendar quarter in our filings. Notable additions at the top of this list include STANDARD BIOTOOLS INC (LAB), HALEON PLC-ADR (HLN), CVS HEALTH CORP (CVS), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC | 71,907,868 | $194.3M | 2 | 1 | 0 | 0 | 3 |
| HLN | HALEON PLC-ADR | 64,776,937 | $592.1M | 0 | 3 | 5 | 1 | 8 |
| CVS | CVS HEALTH CORP | 15,619,321 | $1.3B | 3 | 5 | 12 | 3 | 21 |
| BMY | BRISTOL-MYERS SQUIBB CO | 5,514,784 | $511.4M | 3 | 8 | 7 | 4 | 19 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 5,269,791 | $771.7M | 3 | 5 | 4 | 1 | 16 |
| AVTR | AVANTOR INC | 5,097,260 | $325.3M | 3 | 2 | 2 | 1 | 10 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 5,012,517 | $794.0M | 1 | 3 | 9 | 0 | 14 |
| ZTS | ZOETIS INC | 4,611,984 | $398.4M | 4 | 5 | 7 | 1 | 17 |
| ABT | ABBOTT LABORATORIES | 4,248,840 | $462.5M | 2 | 7 | 7 | 2 | 21 |
| RXRX | RECURSION PHARMACEUTICALS-A | 3,950,248 | $41.7M | 1 | 1 | 1 | 0 | 3 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,922,400 | $55.0M | 1 | 0 | 1 | 0 | 2 |
| ABSI | ABSCI CORP | 3,276,794 | $18.6M | 1 | 0 | 1 | 0 | 2 |
| PRME | PRIME MEDICINE INC | 3,164,192 | $14.2M | 0 | 2 | 0 | 0 | 2 |
| LFST | LIFESTANCE HEALTH GROUP INC | 3,018,143 | $4.4M | 1 | 1 | 0 | 0 | 2 |
| NVST | ENVISTA HOLDINGS CORP | 2,888,882 | $51.5M | 2 | 1 | 2 | 0 | 5 |
| DOCS | DOXIMITY INC-CLASS A | 2,784,328 | $66.2M | 1 | 2 | 2 | 1 | 5 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,446,366 | $887.5K | 1 | 4 | 2 | 1 | 7 |
| BAYRY | BAYER AG-SPONSORED ADR | 2,386,640 | $17.2M | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 2,327,309 | $10.9M | 2 | 2 | 1 | 0 | 5 |
| IMVT | IMMUNOVANT INC | 2,130,572 | $58.5M | 1 | 1 | 0 | 0 | 2 |
| OGN | ORGANON & CO | 1,757,042 | $54.1M | 2 | 3 | 1 | 1 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 1,710,007 | $157.7M | 2 | 2 | 6 | 0 | 11 |
| MRK | MERCK & CO. INC. | 1,585,111 | $322.6M | 4 | 6 | 15 | 2 | 28 |
| OPK | OPKO HEALTH INC | 1,378,196 | $1.7K | 1 | 0 | 0 | 0 | 1 |
| HUM | HUMANA INC | 1,374,030 | $544.8M | 4 | 3 | 3 | 1 | 10 |
| ME | 23ANDME HOLDING CO -CLASS A | 1,370,100 | -$598 | 0 | 1 | 0 | 0 | 1 |
| ADMA | ADMA BIOLOGICS INC | 1,070,384 | $808.9K | 1 | 1 | 0 | 0 | 2 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | 1,052,728 | $21.2M | 2 | 0 | 0 | 0 | 2 |
| MRNA | MODERNA INC | 1,041,861 | $105.0M | 3 | 4 | 5 | 0 | 13 |
| UNH | UNITEDHEALTH GROUP INC | 1,036,252 | $152.5M | 3 | 17 | 12 | 3 | 37 |
| ACB | AURORA CANNABIS INC | 933,738 | $325.0K | 2 | 0 | 0 | 0 | 2 |
| VXRT | VAXART INC | 881,800 | $7.0K | 0 | 1 | 0 | 0 | 2 |
| FOLD | AMICUS THERAPEUTICS INC | 878,800 | $10.2K | 0 | 1 | 0 | 0 | 1 |
| COO | COOPER COS INC/THE | 852,230 | $72.4M | 4 | 0 | 0 | 0 | 4 |
| IKNA | IKENA ONCOLOGY INC | 776,600 | $1.1K | 1 | 0 | 0 | 0 | 1 |
| VREX | VAREX IMAGING CORP | 769,124 | $10.7M | 0 | 2 | 1 | 0 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | 721,400 | $21.9K | 0 | 2 | 0 | 0 | 2 |
| DXCM | DEXCOM INC | 718,550 | $31.6M | 2 | 2 | 4 | 1 | 9 |
| IMUX | IMMUNIC INC | 672,465 | $874 | 0 | 1 | 0 | 0 | 1 |
| PGNY | PROGYNY INC | 667,502 | $23.0M | 2 | 2 | 0 | 0 | 4 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 661,000 | $2.2M | 1 | 1 | 0 | 0 | 3 |
| CARA | CARA THERAPEUTICS INC | 638,406 | $306.0K | 0 | 2 | 0 | 0 | 2 |
| CERS | CERUS CORP | 626,070 | -$4.5M | 0 | 1 | 1 | 0 | 2 |
| FTRE | FORTREA HOLDINGS INC | 618,226 | $6.3M | 1 | 2 | 1 | 2 | 5 |
| LLY | ELI LILLY & CO | 617,280 | $1.4B | 3 | 7 | 11 | 2 | 22 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 598,903 | -$1.7M | 0 | 2 | 0 | 0 | 2 |
| VNDA | VANDA PHARMACEUTICALS INC | 594,500 | $2.0K | 0 | 1 | 0 | 0 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 576,100 | $20.5K | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 572,212 | $4.5M | 2 | 1 | 0 | 0 | 3 |
| CNC | CENTENE CORP | 564,424 | $63.8M | 2 | 2 | 4 | 3 | 8 |